Fig. 2From: Co-expression and prognosis analyses of GLUT1–4 and RB1 in breast cancerThe expression of SLC2A1–4 in pan-cancer and breast cancer (GEPIA). (A)-(D): The expression of SLC2A1–4 (GLUT1–4) in pan-cancer (BRCA: Breast invasive carcinoma); (E)-(F): The expression of SLC2A1–4 in breast cancer (BRCA: Breast invasive carcinoma). Please see supplementary Table S1 for all the cancer type abbreviations in PEGIABack to article page